CVRx, Inc.

CVRX Nasdaq CIK: 0001235912

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 9201 WEST BROADWAY AVENUE, MINNEAPOLIS, MN, 55445
Mailing Address 9201 WEST BROADWAY AVENUE, MINNEAPOLIS, MN, 55445
Phone 7634162850
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

$65.47M
Total Liabilities
$75.95M
Stockholders' Equity
$-2.04
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report February 13, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
424B5 Prospectus supplement January 12, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 12, 2026 View on SEC
4/A Insider transaction amendment January 8, 2026 View on SEC
4 Insider stock transaction report December 1, 2025 View on SEC
4 Insider stock transaction report November 25, 2025 View on SEC
4 Insider stock transaction report November 14, 2025 View on SEC

Annual Reports

10-K February 13, 2026
  • Barostim, the flagship product, has U.S. FDA Breakthrough Device designation and full FDA approval for heart failure patients.
  • Achieved significant revenue growth of 67% to $50.3 million in FY2025, primarily driven by increased Barostim adoption in the U.S. market.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.